National Cancer Institute; Notice of Meetings, 61017-61018 [2020-21401]

Download as PDF Federal Register / Vol. 85, No. 189 / Tuesday, September 29, 2020 / Notices Public participants may also submit written statements as further described below. To submit written comments or to request time for an oral comment at the meeting, please register online by 12:00 p.m. ET on October 28, 2020. Information about CHAC can be found on the CHAC website at https:// www.cdc.gov/maso/facm/ facmCHACHSPT.html. Visit the meeting information page for additional details https://chacfall2020.org. Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Theresa Jumento at the email address and phone number listed above at least 10 business days prior to the meeting. Maria G. Button, Director, Executive Secretariat. BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting jbell on DSKJLSW7X2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA SEP for Career Development (K99/R00 and K12 applications). Date: November 4, 2020. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sindhu Kizhakke Madathil, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, Division of Extramural Research, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, 3 WFN 9th Floor, MSC 6021, Bethesda, MD 20892, (301) 827–5702, sindhu.kizhakkemadathil@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist 18:14 Sep 28, 2020 Jkt 250001 Dated: September 23, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–21497 Filed 9–28–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meetings [FR Doc. 2020–20943 Filed 9–28–20; 8:45 am] VerDate Sep<11>2014 Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of meetings of the President’s Cancer Panel. The meetings will be held as virtual meetings and are open to the public. Individuals who plan to view the virtual meetings and need special assistance or other reasonable accommodations to view the meetings should notify the Contact Person listed below in advance of the meetings. The meetings can be accessed by clicking on the following link: https://nci.rev.vbrick.com/#/ webcasts/presidentscancerpanel. Name of Committee: President’s Cancer Panel. Date: November 2, 2020. Time: 1:00 p.m. to 5:00 p.m. Agenda: Improving Resilience and Equity in Cancer Screening: Lessons from COVID–19 and Beyond (Day 1—Colorectal Cancer). Place: National Cancer Institute, 31 Center Drive, Building 31, Room 11A48, Rockville, MD 20850, (Virtual Meeting). Access to Meeting: https:// nci.rev.vbrick.com/#/webcasts/ presidentscancerpanel. Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, President’s Cancer Panel, Special Assistant to the Director, National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 2590, Bethesda, MD 20892, 240–781–3327, johnsonr@mail.nih.gov. Name of Committee: President’s Cancer Panel. Date: November 4, 2020. Time: 1:00 p.m. to 5:00 p.m. Agenda: Improving Resilience and Equity in Cancer Screening: Lessons from COVID–19 and Beyond (Day 2—Colorectal Cancer). Place: National Cancer Institute, 31 Center Drive, Building 31, Room 11A48, Rockville, MD 20850 (Virtual Meeting). Access to Meeting: https:// nci.rev.vbrick.com/#/webcasts/ presidentscancerpanel. PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 61017 Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, President’s Cancer Panel, Special Assistant to the Director, National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 2590, Bethesda, MD 20892, 240–781–3327, johnsonr@mail.nih.gov. Name of Committee: President’s Cancer Panel. Date: November 9, 2020. Time: 1:00 p.m. to 5:00 p.m. Agenda: Improving Resilience and Equity in Cancer Screening: Lessons from COVID–19 and Beyond (Day 1—Cervical Cancer). Place: National Cancer Institute, 31 Center Drive, Building 31, Room 11A48, Rockville, MD 20850, (Virtual Meeting). Access to Meeting: https:// nci.rev.vbrick.com/#/webcasts/ presidentscancerpanel. Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, President’s Cancer Panel, Special Assistant to the Director, National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 2590, Bethesda, MD 20892, 240–781–3327, johnsonr@mail.nih.gov. Name of Committee: President’s Cancer Panel. Date: November 10, 2020. Time: 1:00 p.m. to 5:00 p.m. Agenda: Improving Resilience and Equity in Cancer Screening: Lessons from COVID–19 and Beyond (Day 2—Cervical Cancer). Place: National Cancer Institute, 31 Center Drive, Building 31, Room 11A48, Rockville, MD, 20850 (Virtual Meeting). Access to Meeting: https:// nci.rev.vbrick.com/#/webcasts/ presidentscancerpanel. Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, President’s Cancer Panel, Special Assistant to the Director, National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 2590 Bethesda, MD 20892, 240–781–3327, johnsonr@mail.nih.gov. Name of Committee: President’s Cancer Panel. Date: November 16, 2020. Time: 1:00 p.m. to 5:00 p.m. Agenda: Improving Resilience and Equity in Cancer Screening: Lessons from COVID–19 and Beyond (Day 1—Breast Cancer). Place: National Cancer Institute, 31 Center Drive, Building 31, Room 11A48, Rockville, MD 20850, (Virtual Meeting). Access to Meeting: https:// nci.rev.vbrick.com/#/webcasts/ presidentscancerpanel. Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, President’s Cancer Panel, Special Assistant to the Director, National Cancer Institute, NIH, 31 Center Drive, Room 11A48, MSC 2590, Bethesda, MD 20892, 240–781–3327, johnsonr@mail.nih.gov. Name of Committee: President’s Cancer Panel. Date: November 18, 2020. Time: 1:00 p.m. to 5:00 p.m. Agenda: Improving Resilience and Equity in Cancer Screening: Lessons from COVID–19 and Beyond (Day 2—Breast Cancer). E:\FR\FM\29SEN1.SGM 29SEN1 61018 Federal Register / Vol. 85, No. 189 / Tuesday, September 29, 2020 / Notices Place: National Cancer Institute, 31 Center Drive, Building 31, Room 11A48, Rockville, MD 20850 (Virtual Meeting). Access to Meeting: https:// nci.rev.vbrick.com/#/webcasts/ presidentscancerpanel. Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, President’s Cancer Panel, Special Assistant to the Director, National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 2590, Bethesda, MD 20892, 240–781–3327 johnsonr@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/pcp/index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: September 23, 2020. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jbell on DSKJLSW7X2PROD with NOTICES National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special 18:14 Sep 28, 2020 Jkt 250001 Dated: September 24, 2020. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–21496 Filed 9–28–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meetings [FR Doc. 2020–21401 Filed 9–28–20; 8:45 am] VerDate Sep<11>2014 Emphasis Panel; NIAAA Individual Fellowship (F30, F31, F32) Review Panel. Date: October 28, 2020. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700 B Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting) Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer, Extramural Project Review Branch, Office of Extramural Activities, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Room 2109, Bethesda, MD 20892, (301) 443–8599, espinozala@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants; 93.701, ARRA Related Biomedical Research and Research Support Awards., National Institutes of Health, HHS) Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Environmental Health Sciences Core Centers Review Meeting II. Date: October 21–23, 2020. Time: 2:00 p.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Environmental Health Sciences, Keystone Building, 530 Davis Drive, Durham, NC 27709 (Virtual Meeting). PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 Contact Person: Varsha Shukla, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, (984) 287–3288, Varsha.shukla@ nih.gov. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Career Development in K Applications. Date: October 26, 2020. Time: 1:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Environmental Health Sciences, Keystone Building, 530 Davis Drive, Durham, NC 27709 (Virtual Meeting). Contact Person: Laura A. Thomas, Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, (984) 287–3328, laura.thomas@ nih.gov. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Emerging Research Opportunities in Environmental Health Sciences-Population-based Studies. Date: October 27, 2020. Time: 10:00 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Environmental Health Sciences, Keystone Building, 530 Davis Drive, Durham, NC 27709 (Virtual Meeting). Contact Person: Leroy Worth, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, National Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–30/ Room 3171, Research Triangle Park, NC 27709, (984) 287–3340, worth@niehs.nih.gov. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Career Development in K Applications II. Date: October 28, 2020. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Environmental Health Sciences, Keystone Building, 530 Davis Drive, Durham, NC 27709 (Virtual Meeting). Contact Person: Laura A. Thomas, Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, 984–287–3328, laura.thomas@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to E:\FR\FM\29SEN1.SGM 29SEN1

Agencies

[Federal Register Volume 85, Number 189 (Tuesday, September 29, 2020)]
[Notices]
[Pages 61017-61018]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21401]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meetings

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of meetings of the President's Cancer 
Panel.
    The meetings will be held as virtual meetings and are open to the 
public. Individuals who plan to view the virtual meetings and need 
special assistance or other reasonable accommodations to view the 
meetings should notify the Contact Person listed below in advance of 
the meetings. The meetings can be accessed by clicking on the following 
link: https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.

    Name of Committee: President's Cancer Panel.
    Date: November 2, 2020.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Improving Resilience and Equity in Cancer Screening: 
Lessons from COVID-19 and Beyond (Day 1--Colorectal Cancer).
    Place: National Cancer Institute, 31 Center Drive, Building 31, 
Room 11A48, Rockville, MD 20850, (Virtual Meeting).
    Access to Meeting: https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.
    Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, 
President's Cancer Panel, Special Assistant to the Director, 
National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 
2590, Bethesda, MD 20892, 240-781-3327, [email protected].

    Name of Committee: President's Cancer Panel.
    Date: November 4, 2020.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Improving Resilience and Equity in Cancer Screening: 
Lessons from COVID-19 and Beyond (Day 2--Colorectal Cancer).
    Place: National Cancer Institute, 31 Center Drive, Building 31, 
Room 11A48, Rockville, MD 20850 (Virtual Meeting).
    Access to Meeting: https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.
    Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, 
President's Cancer Panel, Special Assistant to the Director, 
National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 
2590, Bethesda, MD 20892, 240-781-3327, jo[email protected].

    Name of Committee: President's Cancer Panel.
    Date: November 9, 2020.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Improving Resilience and Equity in Cancer Screening: 
Lessons from COVID-19 and Beyond (Day 1--Cervical Cancer).
    Place: National Cancer Institute, 31 Center Drive, Building 31, 
Room 11A48, Rockville, MD 20850, (Virtual Meeting).
    Access to Meeting: https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.
    Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, 
President's Cancer Panel, Special Assistant to the Director, 
National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 
2590, Bethesda, MD 20892, 240-781-3327, [email protected].

    Name of Committee: President's Cancer Panel.
    Date: November 10, 2020.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Improving Resilience and Equity in Cancer Screening: 
Lessons from COVID-19 and Beyond (Day 2--Cervical Cancer).
    Place: National Cancer Institute, 31 Center Drive, Building 31, 
Room 11A48, Rockville, MD, 20850 (Virtual Meeting).
    Access to Meeting: https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.
    Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, 
President's Cancer Panel, Special Assistant to the Director, 
National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 2590 
Bethesda, MD 20892, 240-781-3327, [email protected].

    Name of Committee: President's Cancer Panel.
    Date: November 16, 2020.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Improving Resilience and Equity in Cancer Screening: 
Lessons from COVID-19 and Beyond (Day 1--Breast Cancer).
    Place: National Cancer Institute, 31 Center Drive, Building 31, 
Room 11A48, Rockville, MD 20850, (Virtual Meeting).
    Access to Meeting: https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.
    Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, 
President's Cancer Panel, Special Assistant to the Director, 
National Cancer Institute, NIH, 31 Center Drive, Room 11A48, MSC 
2590, Bethesda, MD 20892, 240-781-3327, [email protected].

    Name of Committee: President's Cancer Panel.
    Date: November 18, 2020.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Improving Resilience and Equity in Cancer Screening: 
Lessons from COVID-19 and Beyond (Day 2--Breast Cancer).

[[Page 61018]]

    Place: National Cancer Institute, 31 Center Drive, Building 31, 
Room 11A48, Rockville, MD 20850 (Virtual Meeting).
    Access to Meeting: https://nci.rev.vbrick.com/#/webcasts/presidentscancerpanel.
    Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary, 
President's Cancer Panel, Special Assistant to the Director, 
National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC 
2590, Bethesda, MD 20892, 240-781-3327 [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person. Information is also available 
on the Institute's/Center's home page: https://deainfo.nci.nih.gov/advisory/pcp/index.htm, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 23, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-21401 Filed 9-28-20; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.